Increased cyclin-dependent kinase 6 expression in bladder cancer Corrigendum in /ol/5/6/1979

Wang,Gang; Zheng,Lingyan; Yu,Zhijian; Liao,Guodong; Lu,Liqin; Xu,Rujun; Zhao,Zhongsheng; Chen,Guangdi

doi:10.3892/ol.2012.695

July 2012 Volume 4 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July 2012 Volume 4 Issue 1

Full Size Image

Article

Increased cyclin-dependent kinase 6 expression in bladder cancer

Corrigendum in: /ol/5/6/1979

Authors:
- Gang Wang
- Lingyan Zheng
- Zhijian Yu
- Guodong Liao
- Liqin Lu
- Rujun Xu
- Zhongsheng Zhao
- Guangdi Chen
View Affiliations / Copyright

Affiliations: Division of Urology, The First Hangzhou People Hospital, Hangzhou 310006, P.R. China, Department of Oncology and Radiotherapy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, P.R. China, Department of Oncology, Zhejiang Provincial People's Hospital, Hangzhou 310014, P.R. China, Department of Pathology, The First Hangzhou People Hospital, Hangzhou 310006, P.R. China, Department of Pathology, Zhejiang Provincial People's Hospital, Hangzhou 310014, P.R. China, Department of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, P.R. China
Pages: 43-46
|
Published online on: April 25, 2012

https://doi.org/10.3892/ol.2012.695
Expand metrics +

Abstract

Cyclin-dependent kinase 6 (Cdk6) controls the cell cycle and aberrant expression of Cdk6 is involved in cancer progression. The aim of this study was to investigate the role of Cdk6 in bladder cancer development. Cdk6 expression was examined in 31 cases of bladder cancer and 29 tissues adjacent to bladder transitional cell carcinoma (TCC) using an immunohistochemistry assay. The correlation between Cdk6 expression and clinical characteristics was also analyzed. Compared with the adjacent tissues, cytoplasmic and nuclear Cdk6 expression levels were significantly increased in the invasive bladder cancer cases (P=0.005 and P<0.001, respectively), but not in the non-invasive superficial cases of bladder cancer (P>0.05 for both). Cytoplasmic and nuclear Cdk6 expression levels were correlated with bladder cancer stage (superficial vs. invasive, P=0.026 and P=0.006, respectively). The results therefore indicate that increased Cdk6 expression contributes to bladder cancer development and may serve as a biomarker for bladder cancer.

View Figures

View References

1	Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
2	Kaufman DS, Shipley WU and Feldman AS: Bladder cancer. Lancet. 374:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
3	Pryor WA: Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect. 105(Suppl 4): 875–882. 1997. View Article : Google Scholar : PubMed/NCBI
4	Franekova M, Halasova E, Bukovska E, et al: Gene polymorphisms in bladder cancer. Urol Oncol. 26:1–8. 2008. View Article : Google Scholar
5	Murray AW: Recycling the cell cycle: cyclins revisited. Cell. 116:221–234. 2004. View Article : Google Scholar : PubMed/NCBI
6	Santamaria D and Ortega S: Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci. 11:1164–1188. 2006. View Article : Google Scholar : PubMed/NCBI
7	Meyerson M and Harlow E: Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol. 14:2077–2086. 1994.PubMed/NCBI
8	Lee KH, Lotterman C, Karikari C, et al: Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology. 9:293–301. 2009. View Article : Google Scholar : PubMed/NCBI
9	Chilosi M, Doglioni C, Yan Z, et al: Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am J Pathol. 152:209–217. 1998.PubMed/NCBI
10	Costello JF, Plass C, Arap W, et al: Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res. 57:1250–1254. 1997.PubMed/NCBI
11	Mendrzyk F, Radlwimmer B, Joos S, et al: Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. J Clin Oncol. 23:8853–8862. 2005. View Article : Google Scholar : PubMed/NCBI
12	Raspollini MR, Nesi G, Baroni G, et al: p16(INK4a) expression in urinary bladder carcinoma. Arch Ital Urol Androl. 78:97–100. 2006.PubMed/NCBI
13	Shariat SF, Tokunaga H, Zhou J, et al: p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol. 22:1014–1024. 2004. View Article : Google Scholar : PubMed/NCBI
14	Chen G, Cheng Y, Zhang Z, et al: Prognostic significance of cytoplasmic p27 expression in human melanoma. Cancer Epidemiol Biomarkers Prev. 20:2212–2221. 2011. View Article : Google Scholar : PubMed/NCBI
15	Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 8:138–140. 1987.(In German).
16	Rodriguez-Otero P, Roman-Gomez J, Vilas-Zornoza A, et al: Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. Br J Haematol. 155:73–83. 2011. View Article : Google Scholar
17	Russo AA, Tong L, Lee JO, et al: Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature. 395:237–243. 1998. View Article : Google Scholar : PubMed/NCBI
18	Eissa S, Ahmed MI, Said H, et al: Cell cycle regulators in bladder cancer: relationship to schistosomiasis. IUBMB Life. 56:557–564. 2004. View Article : Google Scholar : PubMed/NCBI
19	Osman HG, Abadeer NY, Mohamed SE and Fahmy AK: Expression of p16, p15 and Cyclin D1 in bladder cancer and correlation with cancer progression. Internet J Urol. 4:http://www.ispub.com/journal/the-internet-journal-of-urology/volume-4-number-2/expression-of-p16-p15-and-cyclin-d1-in-bladder-cancer-and-correlates-with-cancer-progression-and-clinical-out-come.html.